PF-04494700 IN PARTICIPANTS WITH MILD-TO-MODERATE ALZHEIMERS'S DISEASE

PF-04494700 适用于患有轻度至中度阿尔茨海默病的参与者

• 批准号: 7719083
• 负责人: Paul S. Aisen
• 金额: $ 0.29万
• 依托单位: GEORGETOWN UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2008
• 资助国家: 美国
• 起止时间: 2008-04-01 至 2009-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7719083
• 关键词: Clinical Trials; Computer Retrieval of Information on Scientific Projects Database; Condition; Disease; Funding; Genomics; Grant; Institution; Investigation; Natural History; Participant; Pharmaceutical Preparations; Research; Research Personnel; Resources; Sampling; Source; United States National Institutes of Health; Variant; disease characteristic; response

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The primary objective of this study is to collect, store, and use samples to investigate possible associations between genomic and metabonomic variation in relation to response to the study drugs and in relation to characteristics of the disease/condition under study in the associated clinical trial, and related conditions. In addition, samples may be used as controls in genomic and metabonomic investigations of the causes, natural history, and other aspects of important diseases and conditions.

这个子项目是许多研究子项目中的一个 由NIH/NCRR资助的中心赠款提供的资源。子项目和 研究者（PI）可能从另一个NIH来源获得了主要资金， 因此可以在其他CRISP条目中表示。所列机构为 研究中心，而研究中心不一定是研究者所在的机构。 本研究的主要目的是收集、储存和使用样本，以研究基因组学和代谢组学变异与研究药物应答以及相关临床试验中研究的疾病/病症特征和相关病症之间的可能相关性。此外，样品可用作重要疾病和病症的原因、自然史和其他方面的基因组学和代谢组学研究中的对照。